The prognostic value of NRF2 in solid tumor patients: a meta-analysis

Nuclear factor E2-related factor 2 (NRF2), a transcription factor, is known as a potential therapeutic target of solid tumor for that it is a master regulator of the injury and inflammation response, including controlling antioxidant cell progress. Recent studies showed that NRF2 played significant...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lingling, Zhang, Chunze, Qin, Litao, Xu, Jingyue, Li, Xiaobo, Wang, Wenhong, Kong, Lingqin, Zhou, Taizhen, Li, Xichuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787436/
https://www.ncbi.nlm.nih.gov/pubmed/29416692
http://dx.doi.org/10.18632/oncotarget.19838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787436/
https://www.ncbi.nlm.nih.gov/pubmed/29416692
http://dx.doi.org/10.18632/oncotarget.19838

Ejemplares similares